Home › Funds › Point72 Asset Management › PDSB
Point72 Asset Management position in PDSB
PDS BIOTECHNOLOGY CORP · Health Care
Latest position (Q1 2023)7.81K sh
Reported value held$48.04K
Portfolio Weight0.00%
First reportedQ1 2023
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 7.81K | $48.04K | New |
Other funds holding PDSB
- Vanguard Group 1.95M sh · $1.50M · Q4 2025
- BlackRock Inc 607.64K sh · $535.39K · Q2 2026
- Geode Capital Management 587.14K sh · $517.41K · Q2 2026
- Morgan Stanley 313.92K sh · $276.60K · Q2 2026
- Renaissance Technologies 252.20K sh · $222.21K · Q2 2026
- Marshall Wace 147.17K sh · $129.51K · Q2 2026
- Northern Trust Corp 126.50K sh · $111.46K · Q2 2026
- Wells Fargo & Co 109.00K sh · $96.04K · Q2 2026
- BNY Mellon 68.49K sh · $60.35K · Q2 2026
- Citadel Advisors 24.50K sh · $21.59K · Q2 2026
- PNC Financial Services 11.90K sh · $10.48K · Q2 2026
- UBS Group AG 11.12K sh · $9.80K · Q2 2026